Prof Martin Stoddart became Program leader of the newly renamed Regenerative Orthopaedics Program within the ARI in 2020. He also is Focus area Leader for the Progenitor cell biology and mechanoregulation, and Bone Biology Focus areas. Prof Stoddart represents ARI at the AOCMF R&D Commission.
He completed his bachelor studies in Biology at the University of Aberystwyth in 1995. He then spent a year in Davos at AO Research Institute Davos where he completed his M Phil in Cartilage Biology. Between 1996–2000 he completed his doctoral thesis at the University of Nottingham in the field of Cancer Angiogenesis. He then returned to Switzerland to work in the Laboratory for Experimental Cartilage Research in Zürich, initially as a Post Doc and between 2003–2005 as Group Head. During that time, he also took a six-month sabbatical at the Centre for Molecular Orthopaedics, Harvard Medical School, Brigham and Women Hospital, Boston, to learn viral gene transfer techniques. In 2005 he returned to AO Research Institute Davos, where he became Principal Scientist and Focus Area Leader in 2009. He is a lecturer at the ETH Zürich and in 2015 he was awarded Professorship from the Medical Faculty of the Albert-Ludwigs University, Freiburg, Germany. In 2016 he was awarded an Honorary Professorship at the Institute for Science & Technology in Medicine University of Keele, UK. He is a fellow of the Royal Society of Biology and a fellow member of the International Cartilage Regeneration & Joint preservation Society.
His main focus is the use of autologous MSCs and mechanoregulation for the repair of musculoskeletal tissues using a cell therapy approach. To this aim he investigates novel cell identification and isolation methods. His research interests include the mechano-regulation of progenitor cell fate, in particular chondrogenic differentiation. This has led to advances in regenerative rehabilitation and the discovery of novel clinically relevant biomarkers and targets. He is also interested in the mechanisms by which progenitor cells direct cell fate and interact with endogenous cells to effect a repair.
He is the author of over 120 scientific papers and book chapters, is the editor of two books and has 2 accepted patents. He is the chair of the LearnORS Committee of the ORS, member of the TERMIS EU Meeting and Sponsorship Committee, member of the International Consortium for Regenerative Rehabilitation Leadership Council, and the deputy co-chair of the ICRS Basic Science Committee. He is an editor or associate editor for five journals, including Associate Editor, Frontiers in Bioengineering and Biotechnology and scientific editor for eCM Journal. He is the conference chair of the yearly eCM Conference.